Abstract
Purpose: To measure the magnitude and direction of anterior scleral canal opening (ASCO) offset relative to the Bruch membrane opening (BMO) (ASCO/BMO offset) to characterize neural canal obliqueness and minimum cross-sectional area (NCMCA) in 69 highly myopic and 138 healthy, age-matched, control eyes. Design: Cross-sectional study. Methods: Using optical coherence tomography (OCT) scans of the optic nerve head (ONH), BMO and ASCO were manually segmented and their centroids and size and shape were calculated. ASCO/BMO offset magnitude and direction were measured after projecting the ASCO/BMO centroid vector onto the BMO plane. Neural canal axis obliqueness was defined as the angle between the ASCO/BMO centroid vector and the vector perpendicular to the BMO plane. NCMCA was defined by projecting BMO and ASCO points onto a plane perpendicular to the neural canal axis and measuring their overlapping area. Results: ASCO/BMO offset magnitude was greater (highly myopic eyes 264.3 ± 131.1 μm; healthy control subjects 89.0 ± 55.8 μm, P <.001, t test) and ASCO centroid was most frequently nasal relative to BMO centroid (94.2% of eyes) in the highly myopic eyes. BMO and ASCO areas were significantly larger (P <.001, t test), NCMCA was significantly smaller (P <.001), and all 3 were significantly more elliptical (P ≤.001) in myopic eyes. Neural canal obliqueness was greater in myopic (65.17° ± 14.03°) compared with control eyes (40.91° ± 16.22°; P <.001, t test). Conclusions: Our data suggest that increased temporal displacement of BMO relative to the ASCO, increased BMO and ASCO area, decreased NCMCA, and increased neural canal obliqueness are characteristic components of ONH morphology in highly myopic eyes.
Original language | English |
---|---|
Pages (from-to) | 105-119 |
Number of pages | 15 |
Journal | American Journal of Ophthalmology |
Volume | 218 |
DOIs | |
Publication status | Published - Oct 2020 |
Bibliographical note
Funding Information:Funding/Support: Supported by a National Eye Institute Grant (NIH/NEI R01-EY021281), a grant from the Canadian National Institute for the Blind–Canadian Glaucoma Clinical Research Council; with supplemental support from a Mathers Fellowship award; Legacy Good Samaritan Foundation; and Heidelberg Engineering, GmbH, Heidelberg, Germany.
Funding Information:
Funding/Support: Supported by a National Eye Institute Grant (NIH/NEI R01-EY021281), a grant from the Canadian National Institute for the Blind?Canadian Glaucoma Clinical Research Council; with supplemental support from a Mathers Fellowship award; Legacy Good Samaritan Foundation; and Heidelberg Engineering, GmbH, Heidelberg, Germany. JW. Jeoung: None. H. Yang: None. S. Gardiner: Nonfinancial support?Heidelberg Engineering. YX. Wang: None. SW. Hong: None. B. Fortune: Financial support - Legacy Good Samaritan Foundation, Inotek Pharmaceuticals. M. Girard: Financial support - Abyss Processing Pte Ltd. C. Hardin: None. P. Wei: None. M. Nicolela: None. J. R. Vianna: None. B. C. Chauhan: Financial support - Heidelberg Engineering. C. F. Burgoyne: Financial support - NIH/NEI R01-EY021281, Legacy Good Samaritan Foundation, Heidelberg Engineering. The above listed sponsors/funding organizations had no role in the design, conduct, analysis or reporting of this research. Other Acknowledgments: All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. Financial Disclosures: All authors attest that they meet the current ICMJE criteria for authorship.
Publisher Copyright:
© 2020 Elsevier Inc.
ASJC Scopus Subject Areas
- Ophthalmology
PubMed: MeSH publication types
- Comparative Study
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't